Fundacion Butantan

in implementation

The purpose of the operation with Fundação Butantan (“Client” or “Butantan”) is to finance the construction of two new pharmaceutical manufacturing and processing units: i) the Egg-based Vaccine Research Center (“CPVO II”), which consists of an Influenza vaccine manufacturing plant; and ii) the Final Processing Center for Immunobiologicals (“CPFI”), which consists of a plant for formulating, filling, lyophilizing, crimping, labeling, and packaging pharmaceutical products (“Project”).The operation will be structured in the form of a loan, with a final term of 10 years, including a 3-year grace period. The project will be developed in the City of São Paulo, Brazil, at the same location where Fundação Butantan currently operates.Addendum:On November 7, 2022, a revised version is uploaded for the Environmental and Social Impact Study.Amendment:The operation’s purpose was modified in 2023 to finance: (i) the Cold Storage Center (“CAR”), (ii) the Central Repository and Biobank (“CRB”), (iii) a Central Vivarium and (iv) a Gas Generation Plant – Cogeneration.  Therefore, a revised version of its Environmental and Social Review Summary as well as an update to its Environmental and Social Action Plan (ESAP) were disclosed in this page.